Vascudyne Overview

  • Founded
  • 2014
  • Status
  • Private
  • Latest Deal Type
  • Angel
  • Latest Deal Amount
  • $1.89M
Latest Deal Amount
  • Investors
  • 1

Vascudyne General Information


Owner and operator of a biotechnology company. The company develops tissue based coronary bypass graft.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
  • 5201 West Park Boulevard
  • Suite 100
  • Plano, TX 75093
  • United States
+1 (443) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Vascudyne Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Angel (individual) 29-Mar-2017 $1.89M 00.000 Completed Startup
1. Accelerator/Incubator Completed Startup
To view Vascudyne’s complete valuation and funding history, request access »

Vascudyne Executive Team (2)

Name Title Board Seat Contact Info
Jeffrey Franco Chief Executive Officer, Director and Board Member
Kemal Schakereli Executive Officer & Board Member
To view Vascudyne’s complete executive team members history, request access »

Vascudyne Board Members (1)

Name Representing Role Since
Kemal Schakereli Vascudyne Executive Officer & Board Member 000 0000
To view Vascudyne’s complete board members history, request access »

Vascudyne Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
UB Incubator Accelerator/Incubator Minority 000 0000 000000 0
To view Vascudyne’s complete investors history, request access »